243 related articles for article (PubMed ID: 32395200)
21. Orbital invasion by periocular basal cell carcinoma.
Leibovitch I; McNab A; Sullivan T; Davis G; Selva D
Ophthalmology; 2005 Apr; 112(4):717-23. PubMed ID: 15808267
[TBL] [Abstract][Full Text] [Related]
22. Oral Hedgehog Pathway Inhibition as a Means for Ocular Salvage in Locally Advanced Intraorbital Basal Cell Carcinoma.
Mathis J; Doerr T; Lin E; Ibrahim SF
Dermatol Surg; 2019 Jan; 45(1):17-25. PubMed ID: 30586344
[TBL] [Abstract][Full Text] [Related]
23. Peri - and Intraocular Mutilating Advanced Squamous Cell Carcinoma: "Monsters Inside Your Body"?
Tchernev G; Lotti T; Lozev I; Maximov GK; Wollina U
Open Access Maced J Med Sci; 2018 Jan; 6(1):132-133. PubMed ID: 29484009
[TBL] [Abstract][Full Text] [Related]
24. A young military pilot presents with a periocular Basal Cell Carcinoma: a case report.
Woolley SD; Hughes C
Travel Med Infect Dis; 2013; 11(6):435-7. PubMed ID: 24201041
[TBL] [Abstract][Full Text] [Related]
25. Hedgehog Pathway Inhibition for Locally Advanced Periocular Basal Cell Carcinoma and Basal Cell Nevus Syndrome.
Ozgur OK; Yin V; Chou E; Ball S; Kies M; William WN; Migden M; Thuro BA; Esmaeli B
Am J Ophthalmol; 2015 Aug; 160(2):220-227.e2. PubMed ID: 25935097
[TBL] [Abstract][Full Text] [Related]
26. Ocular preservation with neoadjuvant vismodegib in patients with locally advanced periocular basal cell carcinoma.
Sagiv O; Nagarajan P; Ferrarotto R; Kandl TJ; Thakar SD; Glisson BS; Altan M; Esmaeli B
Br J Ophthalmol; 2019 Jun; 103(6):775-780. PubMed ID: 30021814
[TBL] [Abstract][Full Text] [Related]
27. Supraestructure maxillectomy and orbital exenteration for treatment of basal cell carcinoma of inferior eyelid: case report and review.
Villalon-Lopez JS; Valle-Mejia CA; Patino-Lara A; Moreno-Perez BA; Munoz-Lopez JA; Alcantar-Andrade A
J Cancer Res Ther; 2006; 2(3):140-3. PubMed ID: 17998694
[TBL] [Abstract][Full Text] [Related]
28. Ocular preservation through limited tumor excision combined with ALA-PDT in patients with periocular basal cell carcinoma.
Li X; Tan L; Kou H; Zhang J; Wang Y; Li G; Lu Y
Photodiagnosis Photodyn Ther; 2019 Sep; 27():291-294. PubMed ID: 31233885
[TBL] [Abstract][Full Text] [Related]
29. The Australian Mohs database, part II: periocular basal cell carcinoma outcome at 5-year follow-up.
Malhotra R; Huilgol SC; Huynh NT; Selva D
Ophthalmology; 2004 Apr; 111(4):631-6. PubMed ID: 15051193
[TBL] [Abstract][Full Text] [Related]
30. Role of Vismodegib in the Management of Advanced Periocular Basal Cell Carcinoma.
Cox KF; Margo CE
Cancer Control; 2016 Apr; 23(2):133-9. PubMed ID: 27218790
[TBL] [Abstract][Full Text] [Related]
31. Periocular cutaneous malignancies: a review of the literature.
Slutsky JB; Jones EC
Dermatol Surg; 2012 Apr; 38(4):552-69. PubMed ID: 22404129
[TBL] [Abstract][Full Text] [Related]
32. [Clinical and histologic features of 141 primary basal cell carcinomas of the periocular region and their rate of recurrence after surgical excision].
Spraul CW; Ahr WM; Lang GK
Klin Monbl Augenheilkd; 2000 Oct; 217(4):207-14. PubMed ID: 11098454
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of Vismodegib (Erivedge) for Basal Cell Carcinoma Involving the Orbit and Periocular Area.
Demirci H; Worden F; Nelson CC; Elner VM; Kahana A
Ophthalmic Plast Reconstr Surg; 2015; 31(6):463-6. PubMed ID: 25675162
[TBL] [Abstract][Full Text] [Related]
34. Management of periocular basal cell carcinoma with modified en face frozen section controlled excision.
Wong VA; Marshall JA; Whitehead KJ; Williamson RM; Sullivan TJ
Ophthalmic Plast Reconstr Surg; 2002 Nov; 18(6):430-5. PubMed ID: 12439056
[TBL] [Abstract][Full Text] [Related]
35. Clinical factors influencing periocular surgical defects after Mohs micrographic surgery.
Carter KD; Nerad JA; Whitaker DC
Ophthalmic Plast Reconstr Surg; 1999 Mar; 15(2):83-91. PubMed ID: 10189634
[TBL] [Abstract][Full Text] [Related]
36. Recommendations for Cost-Conscious Treatment of Basal Cell Carcinoma.
Patel PV; Pixley JN; Dibble HS; Feldman SR
Dermatol Ther (Heidelb); 2023 Sep; 13(9):1959-1971. PubMed ID: 37531073
[TBL] [Abstract][Full Text] [Related]
37. Management of periocular basal cell carcinoma by Mohs micrographic surgery.
Litwin AS; Rytina E; Ha T; René C; Woodruff SA
J Dermatolog Treat; 2013 Jun; 24(3):232-4. PubMed ID: 22551161
[TBL] [Abstract][Full Text] [Related]
38. Periocular basal cell carcinoma: recurrence risk factors/when to reoperate?
Gąsiorowski K; Iwulska K; Zapała J; Wyszyńska-Pawelec G
Postepy Dermatol Alergol; 2020 Dec; 37(6):927-931. PubMed ID: 33603611
[TBL] [Abstract][Full Text] [Related]
39. Recurrence rates of periocular basal cell carcinoma following Mohs micrographic surgery: a retrospective study.
Sin CW; Barua A; Cook A
Int J Dermatol; 2016 Sep; 55(9):1044-7. PubMed ID: 27152747
[TBL] [Abstract][Full Text] [Related]
40. The Australian Mohs database, part I: periocular basal cell carcinoma experience over 7 years.
Malhotra R; Huilgol SC; Huynh NT; Selva D
Ophthalmology; 2004 Apr; 111(4):624-30. PubMed ID: 15051192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
